Did you miss ASH 2020? The GvHD Hub attended the 62nd ASH Annual Meeting & Exposition, December 5-8 2020, and has developed a downloadable resource on the practice-changing abstracts in graft-versus-host disease (GvHD).
In this updated resource, you will find comments from the GvHD Hub Steering Committee members on novel treatments, ruxolitinib and belumosudil for steroid-refractory chronic GvHD.